Drug Database
Back to search

Netherlands· NL-fc863b0efc0f

Baraclude 0,5 mg, filmomhulde tabletten

A entecavir product containing entecavir, registered in Netherlands by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 17 of our 19 countries.

ATC J05AF10

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBaraclude 0,5 mg, filmomhulde tablett…ATCJ05AF10REGISTER NO.NL-fc863b0efc0fPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about entecavirAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Entecavir is registered in 17 of 19 countries.

Countries holding a registration under ATC J05AF10 (entecavir), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search entecavir products by name

Entecavir · ATC J05AF10

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of entecavir costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), the median price runs from $0.20 in United States to $12.37 in Switzerland — a ×61 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Entecavir · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$12.37
  • FR France$7.50
  • IT Italy$4.93
  • US United States$0.20 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ENTECAVIR
Manufacturer
Bristol-Myers Squibb Pharma EEIG
Country
Netherlands (NL)
ATC code
J05AF10
ATC class
Entecavir
Defined daily dose
0.5 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/06/343

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

56 interactions on record for entecavir.

Graded by severity as the source publishes them — 56 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check entecavir against other medicinesHow interaction checks work

Entecavir · interactions on record

56 records

  • 56 moderate

Most severe, free to view

  • CimetidineA02BA01moderate
  • RanitidineA02BA02moderate
  • FamotidineA02BA03moderate
  • NeomycinA07AA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Entecavir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All entecavir products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Entecavir Ratiopharm
  • Bulgaria · Ентекавир Pharmascience International Ltd, Ентекавир Зентива
  • Cyprus · Entevirem
  • Czechia · Entecavir Fmk, Entecavir Sandoz
  • Germany · Entecavir Al, Entecavir Amarox
  • Denmark · Edevira, Entecavir Medical Valley
  • Spain · Entecavir Aurovitas, Entecavir Dr. Reddys
  • Finland · Entecavir Stada
  • France · Entecavir Arrow, Entecavir Biogaran
  • United Kingdom (Northern Ireland) · Entecavir Accord-Uk, Entecavir Amarox
  • Greece · Edevira, Entecavir Sandoz
  • Hungary · Entecavir Pharmascience International Ltd, Entecavir Teva
  • Iceland · Baraclude, Entecavir Accord
  • Italy · Entecavir Aristo, Entecavir Aurobindo
  • Liechtenstein · Baraclude, Entecavir Accord
  • Lithuania · Entecavir Sandoz
  • Malta · Entecavir Dr. Reddy's, Entecavir Normon
  • Norway · Baraclude, Entecavir Accord
  • Poland · Entecavir Aurovitas, Entecavir Polpharma
  • Portugal · Entecavir Farmoz, Entecavir Generis
  • Romania · Entecavir Labormed, Entecavir Sandoz
  • Sweden · Entecavir Amarox, Entecavir Medical Valley
  • Slovenia · Entekavir Sandoz, Entekavir Stada
  • Slovakia · Entecavir Fmk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0f74a838-53b8-4e84-b6b1-693481992d31
GET /v1/drugs/0f74a838-53b8-4e84-b6b1-693481992d31?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/baraclude-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Entecavir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp72711",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "LACTOSE 1-WATER",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLYSORBAAT 80 (E 433)",
    "POVIDON K 30 (E 1201)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ENTECAVIR"
  ],
  "leaflet_url": null,
  "authorised_at": "2006/06/26",
  "procedure_number": "EMEA/H/C/000623",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/06/343",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about entecavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console